Tearsheet

Health In Tech (HIT)


Market Price (5/7/2026): $1.52 | Market Cap: $86.5 Mil
Sector: Information Technology | Industry: Application Software

Health In Tech (HIT)


Market Price (5/7/2026): $1.52
Market Cap: $86.5 Mil
Sector: Information Technology
Industry: Application Software

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 71%

Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -56%

Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms, Health Data Analytics, and AI in Healthcare Management.

Weak multi-year price returns
2Y Excs Rtn is -117%, 3Y Excs Rtn is -147%

Stock price has recently run up significantly
12M Rtn12 month market price return is 146%

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.6%

High stock price volatility
Vol 12M is 119%

Key risks
HIT key risks include [1] execution and scalability challenges amid its accelerated growth phase and [2] a demonstrated vulnerability to potential reductions in federal healthcare spending.

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 71%
1 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -56%
2 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms, Health Data Analytics, and AI in Healthcare Management.
3 Weak multi-year price returns
2Y Excs Rtn is -117%, 3Y Excs Rtn is -147%
4 Stock price has recently run up significantly
12M Rtn12 month market price return is 146%
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.6%
6 High stock price volatility
Vol 12M is 119%
7 Key risks
HIT key risks include [1] execution and scalability challenges amid its accelerated growth phase and [2] a demonstrated vulnerability to potential reductions in federal healthcare spending.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Health In Tech (HIT) stock has gained about 30% since 1/31/2026 because of the following key factors:

1. Health In Tech's strong financial performance in 2025 and optimistic 2026 revenue guidance significantly boosted investor confidence. The company reported a 71% year-over-year revenue increase for full-year 2025, reaching $33.3 million, with adjusted EBITDA growing 81% to $4.1 million. Furthermore, Health In Tech projected 2026 revenue between $45 million and $50 million, indicating an anticipated growth of approximately 35% to 50% year-over-year.

2. The strategic expansion of AI-driven self-funded healthcare offerings and key partnerships broadened the company's market reach and technological advantage. On January 7, 2026, Health In Tech announced an expanded portfolio of over 100 pre-configured stop-loss self-funded healthcare plans for employers through a collaboration with Benefit Re. This initiative emphasized faster deployment, scalability, and customizable plans, leveraging the company's AI-driven automation to streamline processes.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 31.0% change in HIT stock from 1/31/2026 to 5/6/2026 was primarily driven by a 48.5% change in the company's P/E Multiple.
(LTM values as of)13120265062026Change
Stock Price ($)1.161.5231.0%
Change Contribution By: 
Total Revenues ($ Mil)31338.5%
Net Income Margin (%)4.7%3.8%-18.0%
P/E Multiple45.567.748.5%
Shares Outstanding (Mil)5657-0.9%
Cumulative Contribution31.0%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 5/6/2026
ReturnCorrelation
HIT31.0% 
Market (SPY)3.6%33.3%
Sector (XLK)18.3%36.3%

Fundamental Drivers

The -42.6% change in HIT stock from 10/31/2025 to 5/6/2026 was primarily driven by a -37.3% change in the company's P/E Multiple.
(LTM values as of)103120255062026Change
Stock Price ($)2.651.52-42.6%
Change Contribution By: 
Total Revenues ($ Mil)273324.9%
Net Income Margin (%)5.1%3.8%-24.8%
P/E Multiple107.867.7-37.3%
Shares Outstanding (Mil)5557-2.7%
Cumulative Contribution-42.6%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 5/6/2026
ReturnCorrelation
HIT-42.6% 
Market (SPY)5.5%24.3%
Sector (XLK)13.4%25.7%

Fundamental Drivers

The 150.4% change in HIT stock from 4/30/2025 to 5/6/2026 was primarily driven by a 71.0% change in the company's Total Revenues ($ Mil).
(LTM values as of)43020255062026Change
Stock Price ($)0.611.52150.4%
Change Contribution By: 
Total Revenues ($ Mil)193371.0%
Net Income Margin (%)3.4%3.8%11.5%
P/E Multiple49.467.736.8%
Shares Outstanding (Mil)5557-4.1%
Cumulative Contribution150.4%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2025 to 5/6/2026
ReturnCorrelation
HIT150.4% 
Market (SPY)30.4%21.6%
Sector (XLK)62.9%20.7%

Fundamental Drivers

null
null

Market Drivers

4/30/2023 to 5/6/2026
ReturnCorrelation
HIT  
Market (SPY)78.7%15.4%
Sector (XLK)130.2%14.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
HIT Return---5%-70%-3%-70%
Peers Return31%15%-7%-18%-13%8%8%
S&P 500 Return27%-19%24%23%16%6%93%

Monthly Win Rates [3]
HIT Win Rate---100%67%60% 
Peers Win Rate52%60%43%48%55%40% 
S&P 500 Win Rate75%42%67%75%67%60% 

Max Drawdowns [4]
HIT Max Drawdown---0%-90%-37% 
Peers Max Drawdown-7%-11%-20%-24%-32%-21% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: UNH, ELV, CI, HUM, CNC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/6/2026 (YTD)

How Low Can It Go

Event

Compare to UNH, ELV, CI, HUM, CNC

In The Past

null

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

Event

Compare to UNH, ELV, CI, HUM, CNC

In The Past

null

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Health In Tech (HIT)

Our Mission To change the non-transparent $4.5 trillion(1) healthcare industry with innovation that removes friction and complexities with vertical integration, process simplification, automation, and digitalization. Health in Tech (“HIT”) is an insurance technology platform company, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Marketplace: We are a health insurance marketplace where insurance companies can list various stop-loss policy options for self-funded benefits plans. Licensed brokers registered on our platform can log in, upload certain required information, select policy plans, obtain a bindable quote and sell them to small businesses. Our technology enables us to medically underwrite insurance policies and usually produce bindable quotes within approximately two minutes, allowing us to deliver an integrated and seamless sales cycle. Customizable Solutions: Beyond policy underwriting and sales, our marketplace offers customization of health benefits plans, vendors, claims, and network services. Brokers can select customized plans that suit their customers. Accessibility and Savings: We make self-funded benefits plans and stop loss insurance accessible online for small businesses. We aim to deliver meaningful cost savings for low-risk, small employers with comparatively healthy employees through a digital medical underwriting process. We seek to deliver time savings for employers, brokers, TPAs, and carriers, by leveraging both external and internally developed technology. HIT was founded on the belief that self-funded benefits plans and stop loss insurance should be simple and streamlined with significant transparency. With over 30 years of industry experience of our management team, we understand the complexities of the healthcare insurance market, and we know how to integrate the multifaceted aspects of the industry. Our solutions and technology platforms do exactly this through vertical integration, process simplification, automation, and digitalization. 1) The total healthcare spending in the U.S. in 2022. According to The Centers for Medicare & Medicaid Services — National Health Expenditure Data; Frost & Sullivan --- We were incorporated in Nevada in November 2021. We have our headquarters in Stuart, Florida, with many of our team members working remotely throughout the United States. Our principal executive office is located at 701 S. Colorado Ave, Suite 1, Stuart, FL. In September 2013, our founder, Tim Johnson, established International Captive Exchange, LLC, an Iowa limited liability company, which as of November 2021 is our wholly-owned subsidiary. In March 2022, International Captive Exchange merged with DIYBS, LLC, an Iowa limited liability company, with International Captive Exchange surviving the merger. In December 2014, our founder, Tim Johnson, established Stone Mountain Risk, LLC, an Iowa limited liability company, which as of November 2021, is a wholly owned subsidiary of HIT. In March 2017, Mr. Johnson, established HI Card LLC, an Iowa limited liability company which as of November 2021, is a wholly owned subsidiary of HIT.

AI Analysis | Feedback

Here are 1-3 brief analogies to describe Health In Tech (HIT):

  • It's like a Kayak or Expedia for comparing and purchasing stop-loss health insurance policies for small businesses.
  • Think of it as the Carvana for simplifying the online purchase of self-funded health plans and stop-loss insurance.

AI Analysis | Feedback

  • Health Insurance Marketplace: An online platform where insurance companies list stop-loss policy options for self-funded benefits plans, and licensed brokers can obtain bindable quotes to sell to small businesses.
  • Medical Underwriting Services: Technology-driven services that rapidly medically underwrite insurance policies and generate bindable quotes, streamlining the sales cycle.
  • Customizable Benefits Plan Solutions: Services offered through the marketplace for tailoring health benefits plans, vendors, claims, and network services to suit customer needs.

AI Analysis | Feedback

Health In Tech (HIT) primarily serves other companies through its insurance technology platform. The company's major customers are categories of businesses rather than specific named entities provided in the description. These customer categories include:

  • Insurance Companies (Carriers): These companies list various stop-loss policy options for self-funded benefits plans on HIT's marketplace.
  • Licensed Brokers: Brokers register on the platform to access policy options, obtain bindable quotes, and sell them to small businesses.
  • Third-Party Administrators (TPAs): TPAs are mentioned as benefiting from the platform's efficiencies and time savings, implying they are users or partners.

While the platform ultimately facilitates access to self-funded benefits plans and stop-loss insurance for small businesses, HIT's direct customers for its technology and services are the insurance carriers, licensed brokers, and TPAs.

AI Analysis | Feedback

null

AI Analysis | Feedback

Tim Johnson, Chief Executive Officer and Director

Mr. Johnson has served as Chief Executive Officer and as a member of Health In Tech's board of directors since its founding in 2014. He is also the Founder and Chairman of Health In Tech. Mr. Johnson has over 30 years of experience as an entrepreneur and has founded multiple successful companies in the medical insurance sectors. He possesses extensive knowledge in stop loss insurance and the self-funded benefits space. Mr. Johnson received his Master of Business Analytics from Missouri Western State College in 1988.

Julia Qian, Chief Financial Officer and Director

Ms. Qian has served as Chief Financial Officer since September 2022 and as a member of the board of directors since April 2024. Her responsibilities include financial accounting and capital markets. Before joining Health In Tech, Ms. Qian was Managing Director at The Blueshirt Group from December 2018 to September 2022. She also held various leadership roles at Citi from April 2012 to November 2018, including Senior Vice President of US retail banking and distribution, Strategy lead of Global Consumer Bank, and Regional director of secured lending Asia. Ms. Qian has over 20 years of leadership experience in global financial services, capital markets, and Fortune 100 companies.

Dustin Plantholt, Chief AI & Marketing Officer

Mr. Plantholt has been Chief AI & Marketing Officer since September 2025, previously serving as Chief Growth Officer from March 2025 to August 2025. He is responsible for leading enterprise-wide artificial intelligence initiatives and marketing strategy, driving Health In Tech's innovation and expansion. With over 20 years of experience in insurance, emerging technology, and media, Mr. Plantholt has successfully built, scaled, and exited multiple companies. He was named Entrepreneur's Metaverse Advisor of the Year in 2022.

Sri Rajagopalan, Chief Technology Officer

Mr. Rajagopalan has served as Health In Tech's Chief Technology Officer since February 2026, and prior to that, he was the Interim CTO from November 2025 to February 2026. He oversees end-to-end product engineering and enterprise platform operations, and is responsible for advancing Health In Tech's next-generation technology architecture, AI development roadmap, and embedding artificial intelligence, automation, and data intelligence across workflows. His previous roles include Senior Vice President of Software Engineering at Net Health and Senior Vice President of Platform Engineering and Enterprise Architecture at Zelis.

Jonathan Lockett, Chief Strategy Officer

Mr. Lockett has been Health In Tech's Chief Strategy Officer since March 2025. He previously served as Chief Operating Officer from January 2022 to March 2025 and initially joined the company as National Sales Director in June 2019.

AI Analysis | Feedback

Here are the key risks for Health In Tech (HIT):

  1. Market Adoption and Intense Competition: Health In Tech operates in the complex and heavily entrenched $4.5 trillion healthcare industry, aiming to disrupt it with innovation, process simplification, and digitalization. Established players benefit from years of claims history, significant operational scale, and strong brand recognition, creating substantial barriers for new entrants. There is a risk that insurance companies, licensed brokers, and small businesses may be slow to adopt HIT's marketplace and digital solutions, or that larger competitors could introduce similar offerings with greater resources. The company must effectively convince industry participants to shift from traditional methods to its platform, which requires overcoming inherent skepticism in a sector where people's lives are at stake.
  2. Reliance on Technology and Underwriting Accuracy: Health In Tech's core business model is dependent on its technology platform, particularly its "digital medical underwriting process" which aims to produce bindable quotes within approximately two minutes [cite: BACKGROUND]. The accuracy, robustness, and scalability of this underlying technology, including any integrated third-party AI, are critical. Inaccuracies in underwriting algorithms, which may be based on limited or biased historical data, could lead to incorrect risk assessments, resulting in significant financial losses, reputational damage, or an inability to attract profitable policies. Additionally, any failures, security vulnerabilities, or underperformance of these systems could severely undermine consumer trust and operational efficiency.
  3. Regulatory, Compliance, and Data Privacy Risks: Operating within the highly regulated healthcare and insurance sectors exposes Health In Tech to substantial regulatory and compliance risks. Regulations are constantly evolving and vary significantly by jurisdiction, making it challenging for underwriting systems to adapt quickly and potentially leading to non-compliance, fines, or legal issues. Furthermore, handling sensitive medical and financial data for underwriting and policy management creates significant data privacy and cybersecurity risks. Breaches of personally identifiable information (PII) or non-compliance with data protection laws (such as potential future AI regulations) could result in severe penalties, loss of trust, and damage to the company's reputation.

AI Analysis | Feedback

null

AI Analysis | Feedback

Health In Tech (HIT) operates within several addressable markets in the U.S. healthcare and insurance technology sectors.

  • Stop-Loss Insurance Market (U.S. / North America): The global stop-loss insurance market was valued at USD 27.9 billion in 2024 and is projected to grow to USD 48.35 billion by 2033. Another estimate values the global market at USD 30.4 billion in 2025, reaching an estimated USD 110.7 billion by 2035. North America held the largest share of the stop-loss insurance market in 2024. For context, the self-funded market, based on net employer stop-loss premiums, expanded to over $20 billion in 2019. The small and medium-sized enterprise segment within this market is experiencing the highest growth.

  • Self-Funded Health Plans for Small Businesses (U.S.): The small business health insurance market in the U.S., which includes self-funded and level-funded plans, was valued at approximately $1.46 billion (USD 1464.3 million) in 2025. This market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5-7% from 2025 to 2033. In 2024, 20% of small businesses in the U.S. offered self-funded health insurance plans.

  • Insurtech Market (U.S.): The U.S. insurtech market has varying estimates for its size. One source valued it at USD 327.17 billion in 2026, with a projection to reach USD 426.96 billion by 2031. Other estimates include a valuation of USD 50.32 billion in 2024, expected to reach USD 71.10 billion by 2030, and an estimated USD 49.83 billion in 2024, projected to reach approximately USD 82.53 billion by 2035. Another report indicated the U.S. insurtech market generated revenue of approximately USD 2.29 billion (USD 2,291.7 million) in 2023 and is expected to reach approximately USD 42.15 billion (USD 42,154.6 million) by 2030.

AI Analysis | Feedback

Health In Tech (HIT) is poised for future revenue growth over the next 2-3 years, driven by several strategic initiatives and market dynamics:

  1. Expansion of Sales Distribution Network and Agency Partnerships: The company is actively expanding its network of licensed brokers, Third-Party Administrators (TPAs), and agencies. This expansion is leading to increased adoption of its eDIBS platform, resulting in more quotes being bound and sold in real time. For instance, the number of partners grew to 849 by September 30, 2025, a 57% year-over-year increase.
  2. Growth in Billed Enrolled Employees: A key driver of revenue is the increasing number of enrolled employees utilizing Health In Tech's platform. The company reported a significant rise in total billable enrolled employees, reaching 24,307 in Q1 2025, up from 20,802 in the same period last year. By Q3 2025, this number further increased to 25,248.
  3. Introduction and Enhancement of AI-Powered Products and Platform Features: Health In Tech is investing heavily in innovation, particularly in AI-backed underwriting and new platform features. The company has introduced significant product innovations, including a blockchain initiative and AI-driven services, and is preparing to launch its next-generation AI Engine. These technological advancements aim to streamline processes, remove complexities, and improve the overall efficiency of the healthcare and insurance industries.
  4. Strategic Market Expansion within the Self-Funded Employer Segment: Health In Tech is focused on expanding its presence within the underserved small and medium-sized self-funded employer market. This includes plans to expand into new U.S. regional markets, offering competitive and cost-effective solutions.

AI Analysis | Feedback

Share Issuance

  • Health In Tech completed its Initial Public Offering (IPO) on December 24, 2024, raising $9.2 million through the sale of 2.3 million shares at $4.00 each.
  • The total gross proceeds from the IPO could potentially increase to approximately $10.58 million if the underwriter exercises an option to purchase an additional 345,000 shares.
  • In June 2025, directors received grants of restricted shares of Class A Common Stock under the company's Equity Incentive Plan, including 128,474 restricted shares each for Sanjay Shrestha and Chike Umemezia at $0.62 per share.

Inbound Investments

  • The company secured $9.2 million in capital from its Initial Public Offering (IPO) on December 24, 2024.
  • The net proceeds from the IPO are designated for purposes such as system enhancements, expanding service offerings, developing sales and distribution channels, talent retention, working capital, and other general corporate uses.

Capital Expenditures

  • As of December 31, 2024, cash utilized in investing activities totaled $836,755, primarily allocated to software development.
  • The company plans to continue investing in technology and innovation to advance automation and improve operational efficiency.

Latest Trefis Analyses

Title
0ARTICLES

Trade Ideas

Select ideas related to HIT.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
PLTR_4302026_Monopoly_xInd_xCD_Getting_Cheaper04302026PLTRPalantir TechnologiesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
0.0%0.0%0.0%
ADSK_4102026_Dip_Buyer_FCFYield04102026ADSKAutodeskDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
8.5%8.5%0.0%
BSY_4102026_Dip_Buyer_FCFYield04102026BSYBentley SystemsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
4.2%4.2%0.0%
ENPH_4102026_Dip_Buyer_ValueBuy04102026ENPHEnphase EnergyDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
5.7%5.7%0.0%
BL_4102026_Dip_Buyer_High_CFO_Margins_ExInd_DE04102026BLBlackLineDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
3.2%3.2%-3.0%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

HITUNHELVCIHUMCNCMedian
NameHealth I.UnitedHe.Elevance.Cigna Humana Centene  
Mkt Price1.52367.28374.71281.98246.3355.33264.16
Mkt Cap0.1333.582.474.129.627.251.9
Rev LTM33449,713200,415277,840137,200198,101199,258
Op Inc LTM218,835---1515
FCF LTM-019,6666,4507,6601,2727,1126,781
FCF 3Y Avg118,3484,1407,9431373,7363,938
CFO LTM323,1537,6058,8121,8447,9447,774
CFO 3Y Avg221,8515,3419,2938124,4644,902

Growth & Margins

HITUNHELVCIHUMCNCMedian
NameHealth I.UnitedHe.Elevance.Cigna Humana Centene  
Rev Chg LTM71.0%9.7%9.4%9.3%14.1%17.0%11.9%
Rev Chg 3Y Avg-10.2%7.7%15.2%12.8%10.7%10.7%
Rev Chg Q53.1%2.0%2.6%5.0%23.5%7.1%6.0%
QoQ Delta Rev Chg LTM8.5%0.5%0.6%1.2%5.8%1.7%1.4%
Op Inc Chg LTM54.4%-43.7%----99.6%-43.7%
Op Inc Chg 3Y Avg--10.3%----33.2%-21.7%
Op Mgn LTM4.6%4.2%---0.0%4.2%
Op Mgn 3Y Avg9.1%6.9%---1.4%6.9%
QoQ Delta Op Mgn LTM0.1%-0.0%---0.2%0.1%
CFO/Rev LTM9.4%5.1%3.8%3.2%1.3%4.0%3.9%
CFO/Rev 3Y Avg9.5%5.3%2.8%3.9%0.5%2.5%3.4%
FCF/Rev LTM-0.2%4.4%3.2%2.8%0.9%3.6%3.0%
FCF/Rev 3Y Avg2.8%4.4%2.2%3.4%-0.0%2.0%2.5%

Valuation

HITUNHELVCIHUMCNCMedian
NameHealth I.UnitedHe.Elevance.Cigna Humana Centene  
Mkt Cap0.1333.582.474.129.627.251.9
P/S2.60.70.40.30.20.10.3
P/Op Inc56.617.7---1,815.156.6
P/EBIT51.718.010.87.614.0-4.812.4
P/E67.727.715.711.826.2-4.221.0
P/CFO27.614.410.88.416.13.412.6
Total Yield1.5%6.0%8.2%10.7%5.3%-23.7%5.6%
Dividend Yield0.0%2.4%1.8%2.2%1.4%0.0%1.6%
FCF Yield 3Y Avg-5.2%5.2%9.1%1.9%18.4%5.2%
D/E0.00.20.40.40.50.60.4
Net D/E-0.10.1-0.00.3-0.3-0.3-0.1

Returns

HITUNHELVCIHUMCNCMedian
NameHealth I.UnitedHe.Elevance.Cigna Humana Centene  
1M Rtn7.8%30.5%23.8%2.3%34.9%56.3%27.2%
3M Rtn43.4%34.1%10.7%4.4%28.9%35.1%31.5%
6M Rtn-46.7%13.7%19.1%9.8%-6.2%50.2%11.8%
12M Rtn146.5%-4.3%-7.6%-13.7%-0.6%-7.3%-5.8%
3Y Rtn-70.2%-21.2%-15.3%14.4%-52.3%-19.1%-20.1%
1M Excs Rtn3.8%8.0%8.9%-8.5%13.6%41.1%8.4%
3M Excs Rtn36.4%27.1%3.7%-2.7%21.9%28.1%24.5%
6M Excs Rtn-51.2%4.1%13.5%2.8%-18.7%52.9%3.5%
12M Excs Rtn109.0%-37.1%-38.4%-43.9%-32.9%-37.8%-37.4%
3Y Excs Rtn-146.9%-98.1%-93.4%-59.7%-129.0%-96.1%-97.1%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024
Single Segment19 
Revenues from fees 3
Revenues from underwriting modeling International Captive Exchange (ICE) 3
Total196


Price Behavior

Price Behavior
Market Price$1.52 
Market Cap ($ Bil)0.1 
First Trading Date12/23/2024 
Distance from 52W High-59.7% 
   50 Days200 Days
DMA Price$1.57$3.28
DMA Trendupup
Distance from DMA-3.3%-53.7%
 3M1YR
Volatility95.4%119.6%
Downside Capture0.530.46
Upside Capture227.99169.39
Correlation (SPY)32.7%21.8%
HIT Betas & Captures as of 4/30/2026

 1M2M3M6M1Y3Y
Beta2.272.092.092.082.060.19
Up Beta3.713.373.094.733.44-0.44
Down Beta-27.682.992.163.602.25-0.82
Up Capture101%147%238%-18%225%-0%
Bmk +ve Days15223166141428
Stock +ve Days9182754119165
Down Capture-34%138%131%130%91%79%
Bmk -ve Days4183056108321
Stock -ve Days10223364123161

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HIT
HIT136.4%119.6%1.27-
Sector ETF (XLK)59.0%20.6%2.1420.8%
Equity (SPY)28.5%12.5%1.7821.7%
Gold (GLD)40.6%27.2%1.230.3%
Commodities (DBC)50.9%18.0%2.20-1.3%
Real Estate (VNQ)12.8%13.5%0.653.8%
Bitcoin (BTCUSD)-14.2%42.1%-0.2516.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HIT
HIT-21.8%135.1%0.27-
Sector ETF (XLK)20.1%24.8%0.7214.1%
Equity (SPY)12.7%17.1%0.5815.5%
Gold (GLD)21.0%17.9%0.961.2%
Commodities (DBC)13.9%19.1%0.603.5%
Real Estate (VNQ)3.5%18.8%0.098.8%
Bitcoin (BTCUSD)8.7%56.1%0.3712.3%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HIT
HIT-11.5%135.1%0.27-
Sector ETF (XLK)24.3%24.4%0.9014.1%
Equity (SPY)14.9%17.9%0.7115.5%
Gold (GLD)13.7%16.0%0.711.2%
Commodities (DBC)9.5%17.7%0.453.5%
Real Estate (VNQ)5.7%20.7%0.248.8%
Bitcoin (BTCUSD)68.4%66.9%1.0712.3%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date4152026
Short Interest: Shares Quantity0.8 Mil
Short Interest: % Change Since 3312026140.1%
Average Daily Volume0.1 Mil
Days-to-Cover Short Interest6.6 days
Basic Shares Quantity56.9 Mil
Short % of Basic Shares1.5%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
3/25/2026-11.0%-21.5%-16.6%
11/12/2025-14.9%-35.8%-50.7%
7/21/202525.2%21.5%137.8%
3/17/2025-18.2%-22.8%-15.6%
SUMMARY STATS   
# Positive111
# Negative333
Median Positive25.2%21.5%137.8%
Median Negative-14.9%-22.8%-16.6%
Max Positive25.2%21.5%137.8%
Max Negative-18.2%-35.8%-50.7%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202503/25/202610-K
09/30/202511/12/202510-Q
06/30/202508/08/202510-Q
03/31/202505/09/202510-Q
12/31/202403/17/202510-K
09/30/202412/23/2024424B4
06/30/202408/30/2024S-1
03/31/202406/27/2024DRS/A